WMUK welcomes NICE Guidance for zanubrutinib in England and Wales
NICE has today published its guidance for the use of BTK inhibitor, zanubrutinib, in treating people with Waldenstrom’s macroglobulinaemia
New Waldenstrom’s macroglobulinaemia Guidelines published
The British Society for Haematology have released a new guidelines for the diagnosis and management of